Therapeutic Solutions increases authorized common shares from 4.5B to 5.5B

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.

Authorized common shares increased from 4.5B to 5.5B; total authorized shares now 5.505B including preferred.
Approved via nonunanimous majority written consent on Oct 11, 2023; amendment filed Oct 12, 2023.
Series A Preferred Stock holder (Timothy Dixon and Thomas Ichim) retains effective voting control.
Each common share has one vote; failure to vote or abstention counted as vote against the amendment.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.: Increased authorized common shares from 4,500,000,000 to 5,500,000,000 (effective 2023-10-12).

Change: charter amendment
Effective: 2023-10-12

Exact text from the filing

On October 12, 2023, we caused to be filed with the Nevada Secretary of State a Certificate of Amendment to Articles of Incorporation to effect an amendment (the “Amendment”) increasing the number of common shares which the corporation shall have authority to issue from 4,500,000,000 to 5,500,000,000 shares of common stock having a $.001 par value per share

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001493152-23-037153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.